2023年欧洲艾滋病毒艾滋病监测数据

HIV/AIDS surveillance in Europe2023 data2024 whether permission is needed for that reuse and to obtainpermission from the copyright holder. The risk of claimsresultingfrom infringement of any third-party-ownedcomponent in the work rests solely with the user. Abstract HIV infection continues to affect the health and well-beingof nearly 2.6 million people in the WHO European Region,particularly in the eastern part of the Region. This reportis the latest in a series published jointly by the EuropeanCentre for Disease Prevention and Control (ECDC) and theWHO Regional Office for Europe that has been reportingdata on HIV and AIDS in the WHO European Region and inthe European Union and European Economic Area (EU/EEA)since 2007. It finds that while epidemic patterns and trendsvarywidely across European countries,nearly 113 000people were diagnosed with HIV in the European Region in2023, including around 25 000 in the EU/EEA. Maps.All maps included in this publication are © WorldHealthOrganization 2024.Reproduction or translationof substantial portions of the maps require explicit, priorauthorization of WHO. To request permission to use themaps,please complete the permissions form availablebythislink:https://www.who.int/about/who-we-are/publishing-policies/permissions. General disclaimers.The designations employed and thepresentation of the material in this publication do notimply the expression of any opinion whatsoever on thepart of WHO concerning the legal status of any country,territory, city or area or of its authorities, or concerningthe delimitation of its frontiers or boundaries. Dotted anddashed lines on maps represent approximate border linesfor which there may not yet be full agreement. Keywords ACQUIRED IMMUNODEFICIENCY SYNDROME– EPIDEMIOLOGY AIDS – PREVENTION AND CONTROLDISEASE OUTBREAKS – STATISTICSHIV INFECTIONS – EPIDEMIOLOGYPOPULATION SURVEILLANCE Themention of specific companies or of certainmanufacturers’products does not imply that they areendorsed or recommended by WHO in preference to othersof a similar nature that are not mentioned. Errors andomissions excepted, the names of proprietary products aredistinguished by initial capital letters. © World Health Organization 2024 Somerights reserved.This work is available undertheCreativeCommonsAttribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO;https://creativecommons.org/licenses/by-nc-sa/3.0/igo). All reasonable precautions have been taken by WHO to verifythe information contained in this publication. However, thepublished material is being distributed without warranty ofany kind, either expressed or implied. The responsibilityfor the interpretation and use of the material lies with thereader. In no event shall WHO be liable for damages arisingfrom its use. Under the terms of this licence, you may copy, redistributeand adapt the work for non-commercial purposes, providedthe work is appropriately cited, as indicated below. Inany use of this work, there should be no suggestion thatWHOendorses any specific organization,products orservices. The use of the WHO logo is not permitted. If youadapt the work, then you must license your work underthesame or equivalent Creative Commons licence.Ifyou create a translation of this work, you should add thefollowingdisclaimer along with the suggested citation:“This translation was not created by the World HealthOrganization (WHO). WHO is not responsible for the contentor accuracy of this translation. The original English editionshall be the binding and authentic edition”. The WHO Regional Office for Europe is responsible for theaccuracy of the translation of the Russian summary. © European Centre for Disease Prevention and Control 2024 Thispublication follows WHO terminological practice.Thenames and designations of countries used in thispublication should not be understood as an endorsementby ECDC of the terminology used. The designations used,and the presentation of the maps therein, do not representECDC’s official position on the legal status of any country,territory, city or area or of its authorities, or the delimitationof its frontiers and boundaries. Any mediation relating to disputes arising under the licenceshall be conducted in accordance with the mediation rulesof the World Intellectual Property Organization. (http://www.wipo.int/amc/en/mediation/rules/) Cover picture:NIAID Cataloguing-in-Publication (CIP) data.CIP data are availableathttp://apps.who.int/iris. Suggested citation for full report.WHO Regional Officefor Europe, European Centre for Disease Prevention andControl. HIV/AIDS surveillance in Europe 2024 – 2023 data.Copenhagen: WHO Regional Office for Europe; 2024. Sales, rights and licensing.To purchase WHO publications,seehttp://apps.who.int/bookorders. To submit requests forcommercial use and queries on rights and licensing, seehttp://www.who.int/about/licensing. Suggested citation for tables and figures.WHO RegionalOffice for Europe, European Centre f